FDA approves controversial potent opioid

The U.S. FDA has approved AcelRx Pharmaceuticals ’ Dsuvia sublingual tablet for the management of acute pain in adults that is severe enough to require an opioid analgesic in certified medically supervised healthcare settings.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pain | Pain Management